Cargando…

Management of Chemotherapy Induced Cardiomyopathy

Chemotherapy related cardiac dysfunction (CRCD) is a serious complication of anticancer therapy. CRCD can be classified into two types. Type I CRCD is exemplified by anthracyline- induced cardiac dysfunction and type II CRCD is exemplified by trastuzumab- induced cardiac dysfunction. The mechanism o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saidi, Abdulfattah, Alharethi, Rami
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322442/ https://www.ncbi.nlm.nih.gov/pubmed/22758625 http://dx.doi.org/10.2174/157340311799960681

Ejemplares similares

Chemotherapy Induced Cardiomyopathy: Pathogenesis, Monitoring and Management
por: Shakir, Douraid K., et al.
Publicado: (2009)

Chemotherapy-Induced Cardiomyopathy in Breast Cancer Patients
por: Dalfardi, Behnam, et al.
Publicado: (2014)

Clinical characterization and natural history of chemotherapy‐induced dilated cardiomyopathy
por: Lalario, Andrea, et al.
Publicado: (2022)

Rates and risk of arrhythmias in cancer survivors with chemotherapy-induced cardiomyopathy compared with patients with other cardiomyopathies
por: Fradley, Michael G, et al.
Publicado: (2017)

Chemotherapy induced cardiomyopathy: an overview, imaging features, and future prospective
por: Divito, D, et al.
Publicado: (2015)

Case series, chemotherapy-induced cardiomyopathy: mind the family history!
por: Moghadasi, Setareh, et al.
Publicado: (2021)

Dilated cardiomyopathy following trastuzumab chemotherapy
por: Karmakar, Saurabh, et al.
Publicado: (2012)

Chemotherapy-induced Takotsubo cardiomyopathy, a case report and review of the literature
por: Coen, Matteo, et al.
Publicado: (2017)

Chemotherapy induced right ventricular cardiomyopathy; a systematic review and meta-analysis
por: Theetha Kariyanna, Pramod, et al.
Publicado: (2023)

A case of Takotsubo cardiomyopathy after chemotherapy
por: Malley, Tamir, et al.
Publicado: (2016)

Efficacy and safety of cardiac resynchronization therapy in chemotherapy‐induced cardiomyopathy: A systematic review
por: Shehram, Muhammad, et al.
Publicado: (2023)

Association between ibrutinib and mid-cavitary Takotsubo cardiomyopathy: a case report and a review of chemotherapy-induced Takostubo’s cardiomyopathy
por: Giza, Dana Elena, et al.
Publicado: (2017)

Heart Transplantation for Early-Onset Anthracycline-Induced Cardiomyopathy Within 5 Months of Chemotherapy Completion
por: Kaskinen, Anu K., et al.
Publicado: (2021)

Almanac 2011: Cardiomyopathies. the National Society Journals Present Selected Research That Has Driven Recent Advances in Clinical Cardiology
por: M. Elliott, Perry, et al.
Publicado: (2011)

Characteristics of syncope in patients with dilated cardiomyopathy
por: Rami, Abdel-Hadi, et al.
Publicado: (2016)

Cyclophosphamide-Induced Cardiomyopathy: A Case Report, Review, and Recommendations for Management
por: Dhesi, Sumandeep, et al.
Publicado: (2013)

Sepsis-induced Cardiomyopathy
por: Romero-Bermejo, Francisco J, et al.
Publicado: (2011)

Management of Cardiac Toxicity Induced by Chemotherapy
por: Trapani, Dario, et al.
Publicado: (2020)

Durable Response to Brentuximab Vedotin-Based Chemotherapy in Refractory Hodgkin Lymphoma with Central Nervous System (CNS) Involvement
por: Mociková, Heidi, et al.
Publicado: (2020)

Tachycardia induced Cardiomyopathy
por: Kim, Do Young, et al.
Publicado: (2019)

Diagnosis and management of hypertrophic cardiomyopathy
por: Pantazis, Antonis, et al.
Publicado: (2015)

Practical management of peripartum cardiomyopathy
por: Kim, Mi-Jeong, et al.
Publicado: (2017)

Septic cardiomyopathy: Diagnosis and management()
por: Boissier, Florence, et al.
Publicado: (2021)

Apical Hypertrophic Cardiomyopathy: The Variant Less Known
por: Hughes, Rebecca K., et al.
Publicado: (2020)

Acupuncture for the Management of Chemotherapy-Induced Peripheral Neuropathy
por: Visovsky, Constance
Publicado: (2012)

Management of Patients With Chemotherapy-Induced Nausea and Vomiting
por: Barbour, Sally Yowell
Publicado: (2017)

Turkish Society of Cardiology consensus paper on management of arrhythmia-induced cardiomyopathy
por: Ulus, Taner, et al.
Publicado: (2019)

The role of echocardiography in management of hypertrophic cardiomyopathy
por: Haland, Trine F., et al.
Publicado: (2019)

Tachycardia-induced cardiomyopathy
por: Ahmadi, Alireza, et al.
Publicado: (2014)

Arrhythmia induced cardiomyopathy
por: Sugumar, Hariharan, et al.
Publicado: (2018)

Pacing-induced Cardiomyopathy
por: Koo, Alex, et al.
Publicado: (2017)

Ibrutinib-induced cardiomyopathy
por: Kyi, Htay Htay, et al.
Publicado: (2019)

Osimertinib-Induced Cardiomyopathy
por: Patel, Shruti R., et al.
Publicado: (2020)

Therapeutic potential of extracellular vesicles derived from cardiac progenitor cells in rodent models of chemotherapy-induced cardiomyopathy
por: Desgres, Manon, et al.
Publicado: (2023)

PtdIns(4,5)P2 and PtdIns(3,4,5)P3 dynamics during focal adhesions assembly and disassembly in a cancer cell line
por: ALFAHAD, Dhurgham, et al.
Publicado: (2020)

Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia
por: Hoggatt, Jonathan, et al.
Publicado: (2015)

Mechanism and Management of Cancer Chemotherapy-Induced Atherosclerosis
por: Mukai, Mikio, et al.
Publicado: (2018)

Hair Spray Induced Cardiomyopathy
por: Kashfi, Simon, et al.
Publicado: (2022)

Management of Chemotherapy Induced Nausea and Vomiting in Patients on Multiday Cisplatin Based Combination Chemotherapy
por: Ranganath, Praveen, et al.
Publicado: (2015)

Emergency management of decompensated peripartum cardiomyopathy
por: Lata, Indu, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_neek0dqpdrqf9ci5lp8kmhef2a